| Followers | 5 |
| Posts | 3 |
| Boards Moderated | 0 |
| Alias Born | 02/15/2018 |
Tuesday, April 19, 2022 7:08:07 PM
What you're reading below is an email exchange between me and Denise Heady, a media relations contact at UCLA Jonsson Cancer Center. As you can see, this email exchange took place in the early weeks of 2020, right before Covid shut everything down.
Feel free to confirm on your own. Denise is no longer at UCLA but someone else there can certainly confirm this information. NWBO has no rights to ATL-DC, nor is it involved in the pembrolizumab combination study.
I hope this helps. -- Adam Feuerstein
Recent NWBO News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
